Dainippon Sumitomo to buy U.S. drugmaker Sepracor for $2.6 bil.

TOKYO, Japan - Dainippon Sumitomo Pharma Co. President Masayo Tada speaks about the company's plan to buy U.S. pharmaceutical maker Sepracor Inc. for about $2.6 billion (around 240 billion yen) at a news conference in Tokyo on Sept. 3. Sepracor will become a wholly owned unit of Dainippon Sumitomo Pharma America Holdings Inc., a U.S. subsidiary of the Japanese drugmaker. (Kyodo)

• Product Code
• ILEA000043549

• Registered date
• 2009/9/03 00:00:00

• Credit
• Kyodo / Kyodo News Images

• Media source

• Media size
• 1303 × 1745 pixel

• Resolution
• 240 dpi

• Deployment size
• 491.86(KB)*

• Special instruction

*File size when opened in Photoshop, etc.